Restriction on the re-export of medicinal products and the supervision of compliance with it by public administration bodies

Peráček, Tomáš

Restriction on the re-export of medicinal products and the supervision of compliance with it by public administration bodies / Peráček T. ... [et al.]. -- After years of mainly expert discussions (not only in the Slovak legal environment), the concept of and legislation on re-export offer a sort of solution provided for in the Act no. 306/2016 Coll. Said act amends the key legislation in this field, namely the Act no. 362/2011 Coll. on Medicinal Products and Medical Devices and on the amendment of certain acts, as amended (hereinafter referred to as the "Act on Medicinal Products") and the Act no. 363/2011 Coll. on the Scope and Conditions of Payments for Medicinal Products, Medical Devices and Dietetic Foods from Public Health Insurance and on the amendment of certain acts, as amended (hereinafter referred to as the "Act on Payments"). The topic of the paper belongs in the area of medicinal products and pharmaceutical services, it offers, however, significant overlaps in the area of the constitutional, administrative and European law and is aimed at multidisciplinary research into the issue of the reverse export (re-export) of medicinal

In European Pharmaceutical Journal. -- Bratislava : Univerzita Komenského v Bratislave, 2018. -- ISSN 2453-6725. -- Vol. 65, no. 1 (2018), pp. 24-30